4-Hydroxythiobenzamide CAS 25984-63-8 Purità > 99.0% (HPLC) Febuxostat Fabbrika Intermedja
Ruifu Chemical Supply Febuxostat Intermedji Relatati:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Isem Kimiku | 4-Hydroxythiobenzamide |
Sinonimi | p-Hydroxythiobenzamide;4-Hydroxy-thiobenzamide;p-Hydroxythio-benzamide;4-Hydroxybenzenecarbothioamide;4-Hydroxybenzothioamide |
Numru CAS | 25984-63-8 |
Numru tal-KAT | RF-PI1855 |
Status tal-istokk | Fil-Ħażna, Skala ta' Produzzjoni Sa Tunnellati |
Formula Molekulari | C7H7NOS |
Piż Molekulari | 153.20 |
Punt tat-tidwib | 181.0~185.0℃ |
Densità | 1.338±0.06 g/cm3 |
Solubilità (Solubbli fi) | Solubbli fil-Metanol |
Brand | Ruifu Kimika |
Oġġett | Speċifikazzjonijiet |
Dehra | Trab Solidu Isfar ċar |
Purità / Metodu ta 'Analiżi | >99.0% (HPLC) |
Identifikazzjoni | Permezz HPLC;Minn HNMR |
Telf fuq Tnixxif | <0.50% |
Residwu mat-Tqabbid | <0.20% |
Impurità Unika | <0.50% |
Impuritajiet Totali | <1.00% |
Standard tat-Test | Standard tal-Intrapriża |
Użu | Intermedju ta' Febuxostat (CAS: 144060-53-7) |
Pakkett: Flixkun, borża tal-fojl tal-aluminju, 25kg/Drum tal-Kartun, jew skont il-ħtieġa tal-klijent
Kundizzjoni tal-Ħżin:Aħżen f'kontenituri ssiġillati f'post frisk u niexef;Ipproteġi mid-dawl u l-umdità
4-Hydroxythiobenzamide (CAS: 25984-63-8) jista' jintuża bħala intermedjarju ta' Febuxostat (CAS: 144060-53-7).Febuxostat, inibitur selettiv ta' xanthine oxidase, ġie mniedi għall-ġestjoni kronika ta' iperuriċemija f'pazjenti bil-gotta.L-iperuriċemija hija definita bħala konċentrazzjoni ta' aċidu uriku fis-serum li taqbeż il-limitu tas-solubilità.Jippredisponi lill-persuni affettwati għall-gotta, marda kkaratterizzata mill-formazzjoni ta 'kristalli ta' urat monosodju jew aċidu uriku minn fluwidi supersaturati fil-ġogi u tessuti oħra.